Study report - GWAS of Colorectal cancer (HGVST1828)
Browser options:
No data sets (in No Studies) added to Browser
GWAS Central identifier HGVST1828
Study name GWAS of Colorectal cancer
Total markers imported 14
Phenotype(s) tested
Colorectal cancer
Study design Case-control study
Genotype platforms SNaPshot methodology validated by Sanger sequencing
Abstract To determine if the at-risk single-nucleotide polymorphism (SNP) alleles for colorectal cancer (CRC) could contribute to clinical situations suggestive of an increased genetic risk for CRC, we performed a prospective national case-control study based on highly selected patients (CRC in two first-degree relatives, one before 61 years of age; or CRC diagnosed before 51 years of age; or multiple primary CRCs, the first before 61 years of age; exclusion of Lynch syndrome and polyposes) and controls without personal or familial history of CRC. SNPs were genotyped using SNaPshot, and statistical analyses were performed using Pearson's χ(2) test, Cochran-Armitage test of trend and logistic regression. We included 1029 patients and 350 controls. We confirmed the association of CRC risk with four SNPs, with odds ratio (OR) higher than previously reported: rs16892766 on 8q23.3 (OR: 1.88, 95% confidence interval (CI): 1.30-2.72; P=0.0007); rs4779584 on 15q13.3 (OR: 1.42, CI: 1.11-1.83; P=0.0061) and rs4939827 and rs58920878/Novel 1 on 18q21.1 (OR: 1.49, CI: 1.13-1.98; P=0.007 and OR: 1.49, CI: 1.14-1.95; P=0.0035). We found a significant (P<0.0001) cumulative effect of the at-risk alleles or genotypes with OR at 1.62 (CI: 1.10-2.37), 2.09 (CI: 1.43-3.07), 2.87 (CI: 1.76-4.70) and 3.88 (CI: 1.72-8.76) for 1, 2, 3 and at least 4 at-risk alleles, respectively, and OR at 1.71 (CI: 1.18-2.46), 2.29 (CI: 1.55-3.38) and 6.21 (CI: 2.67-14.42) for 1, 2 and 3 at-risk genotypes, respectively. Combination of SNPs may therefore explain a fraction of clinical situations suggestive of an increased risk for CRC.
Submission information
ContributorDate
Submitted
Author? Submitter? Source?
Thierry Frebourg 2014-11-26 yes yes yes
Author communication info
Corresponding author Date of contact Response received Date of response Type of response info
-- none contacted -- -- -- -- --
Links Not supplied
Background An important fraction of clinical situations suggestive of an increased genetic risk for CRC cannot be explained by a simple Mendelian model involving one of these key CRC genes.  
Objectives To determine if the at risk SNP alleles for colorectal cancer (CRC) could contribute to clinical situations suggestive of an increased genetic risk for CRC.
Key results We confirmed the association of CRC risk with 4 SNPs, with odds ratio (OR) higher than previously reported : rs16892766 on 8q23.3 (OR: 1.88, 95% confidence interval (CI): 1.30-2.72; p=0.0007); rs4779584 on 15q13.3 (OR: 1.42, CI: 1.11-1.83; p=0.0061), and rs4939827 and rs58920878/Novel 1 on 18q21.1 (OR: 1.49, CI: 1.13-1.98; p=0.007 and OR: 1.49, CI: 1.14-1.95; p=0.0035). We found a significant (p< 0.0001) cumulative effect of the at risk alleles or genotypes with OR at 1.62 (CI: 1.10-2.37); 2.09 (CI: 1.43-3.07); 2.87 (CI: 1.76-4.70) and 3.88 (CI: 1.72-8.76) for 1, 2, 3 and at least 4 at risk alleles and OR at 1.71 (CI: 1.18-2.46); 2.29 (CI: 1.55-3.38) and 6.21 (CI: 2.67-14.42) for 1, 2 and 3 at risk genotypes.
Conclusions This study supports that a fraction of clinical situations suggestive of an increased risk for CRC may be explained by a combination of SNPs involved in the genetic determinism of CRC.
Reason for study size Not supplied
Study power Not supplied
Sources of bias Not supplied
Limitations Not supplied
Acknowledgements This work was supported by the French National Cancer Institute (INCa-DGOS_1332).
Related citations
Baert-Desurmont S, Charbonnier F, Houivet E et al.link
Clinical relevance of 8q23, 15q13 and 18q21 SNP genotyping to evaluate colorectal cancer risk.
European journal of human genetics : EJHG 2016;24(1):99-105